A PYMNTS Company

Clifford Chance Grows Antitrust Team

 |  March 14, 2022

Clifford Chance continues antitrust expansion with appointment of life sciences and healthcare partner Leigh Oliver.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Oliver is the third US antitrust partner to join the team in three years. She joins from Hogan Lovells, where she established a leading reputation by helping clients navigate through their most difficult antitrust issues ranging from bet-the-company merger control matters to state and federal antitrust investigations.

    Oliver brings nearly two decades of experience advising clients in some of the most heavily scrutinized industries, including healthcare, life sciences, aerospace and defense, and industrials. She regularly represents clients before federal and state antitrust agencies and in merger litigation in federal court. She is in the leadership of the ABA Antitrust Section and an adjunct professor at The George Washington University Law School.

    “Our team is well-known for its exceptional work across antitrust investigations, merger control and joint venture matters, private and government litigations, and everyday counseling. Welcoming a partner of Oliver’s caliber further deepens our offering at a time when we are experiencing a rise in antitrust enforcement,” said Timothy Cornell, Head of the US Antitrust Practice.

    “Clients commend Leigh for being extraordinarily attentive to detail and strategy, and very responsive — I’m confident that she will deliver immediate value to both our clients and our wider team, all of whom are incredibly excited to welcome her on board.”

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.